118 related articles for article (PubMed ID: 22251621)
1. Comparison of noninvasive photodynamic therapy dosimetry methods using a dynamic model of ALA-PDT of human skin.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2012 Feb; 57(3):825-41. PubMed ID: 22251621
[TBL] [Abstract][Full Text] [Related]
2. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
3. Comparison of photodynamic therapy with different excitation wavelengths using a dynamic model of aminolevulinic acid-photodynamic therapy of human skin.
Liu B; Farrell TJ; Patterson MS
J Biomed Opt; 2012 Aug; 17(8):088001-1. PubMed ID: 23224203
[TBL] [Abstract][Full Text] [Related]
4. Tumor reactive ringlet oxygen approach for Monte Carlo modeling of photodynamic therapy dosimetry.
Lopez N; Mulet R; Rodríguez R
J Photochem Photobiol B; 2016 Jul; 160():383-91. PubMed ID: 27197059
[TBL] [Abstract][Full Text] [Related]
5. Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.
Mallidi S; Anbil S; Lee S; Manstein D; Elrington S; Kositratna G; Schoenfeld D; Pogue B; Davis SJ; Hasan T
J Biomed Opt; 2014 Feb; 19(2):028001. PubMed ID: 24503639
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry model for photodynamic therapy with topically administered photosensitizers.
Svaasand LO; Wyss P; Wyss MT; Tadir Y; Tromberg BJ; Berns MW
Lasers Surg Med; 1996; 18(2):139-49. PubMed ID: 8833282
[TBL] [Abstract][Full Text] [Related]
7. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
8. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
[No Abstract] [Full Text] [Related]
9. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.
Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR
Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462
[TBL] [Abstract][Full Text] [Related]
10. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
11. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas.
Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K
J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097
[TBL] [Abstract][Full Text] [Related]
13. Singlet oxygen model evaluation of interstitial photodynamic therapy with 5-aminolevulinic acid for malignant brain tumor.
Izumoto A; Nishimura T; Hazama H; Ikeda N; Kajimoto Y; Awazu K
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31838789
[TBL] [Abstract][Full Text] [Related]
14. Simulation of fractionated and continuous irradiation in photodynamic therapy: study the differences between photobleaching and singlet oxygen dose deposition.
Naghavi N; Miranbaygi MH; Sazgarnia A
Australas Phys Eng Sci Med; 2011 Jun; 34(2):203-11. PubMed ID: 21448718
[TBL] [Abstract][Full Text] [Related]
15. Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements.
Jarvi MT; Patterson MS; Wilson BC
Biophys J; 2012 Feb; 102(3):661-71. PubMed ID: 22325290
[TBL] [Abstract][Full Text] [Related]
16. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
17. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
19. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Tyrrell J; Campbell S; Curnow A
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
[TBL] [Abstract][Full Text] [Related]
20. In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy.
Laubach HJ; Chang SK; Lee S; Rizvi I; Zurakowski D; Davis SJ; Taylor CR; Hasan T
J Biomed Opt; 2008; 13(5):050504. PubMed ID: 19021376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
